READYSTATE ASSET MANAGEMENT LP
Position in APLS — Apellis Pharmaceuticals, Inc.
CIK 1900923
CHICAGO, IL
Position in APLS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
34,100
-85.9% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APLS Over Time
Shares Held
Position Value (USD)
Derivatives in APLS
reported options exposure · as of Mar 31, 2024CallValue
$0
CallShares
8,800
PutValue
$0
PutShares
10,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026READYSTATE ASSET MANAGEMENT LP holds $170,733,904 across 15 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMNM |
Immunome Inc.
|
1,605,820 | $34,027,325 | |
| 2 | ABVX |
Abivax S.A.
|
241,530 | $32,186,287 | |
| 3 | WVE |
Wave Life Sciences, Inc.
|
4,727,139 | $27,464,677 | |
| 4 | QURE |
uniQure N.V.
|
400,989 | $18,469,553 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
295,114 | $12,663,341 | |
| 6 | PCVX |
Vaxcyte, Inc.
|
156,090 | $9,073,511 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
33,554 | $8,213,012 | |
| 8 | OLMA |
Olema Pharmaceuticals, Inc.
|
593,829 | $7,428,800 |
All Filings in APLS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 34,100 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | — | 241,977 | Shares | Sole | 2025-11-07 | |
| 2024-12-31 | — | 35,561 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | — | 8,800 | Call | Sole | 2024-05-13 | |
| 2024-03-31 | — | 10,700 | Put | Sole | 2024-05-13 | |
| 2024-03-31 | — | 5,438 | Shares | Sole | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||